Protecting Surgeons’ Vision: The Critical Role of Laser Safety Glasses in Modern Operating Rooms

Surgeons face numerous risks during procedures, with eye protection being a paramount concern. Protecting surgeons’ vision is crucial, and laser safety glasses play a critical role in modern operating rooms by shielding eyes from potentially harmful laser exposure. Investing in these specialized eyewear solutions is essential for maintaining surgeon precision and eye health. In the […]
Cellular Degeneration: What Science Is Telling Us So Far
Cellular degeneration—the gradual deterioration of cells that contributes to aging and disease—has become a central focus of modern medical research. As our understanding of the molecular mechanisms behind aging deepens, scientists are uncovering fascinating insights about how our cells change over time and what might be done to slow or potentially reverse these processes. This […]
The Dangers of Undiagnosed Sleep Apnea: How At-Home Diagnostics Is Revolutionizing Detection and Enabling Life-Saving Treatment | By R. Kirk Huntsman, Chairman, CEO, and Co-Founder of Vivos Therapeutics

Discover how at-home diagnostics are transforming the detection of undiagnosed sleep apnea and enabling essential treatments.
A New Future for PTSD Treatment: Drug-Free, Trauma-Free, Brain-Powered

Explore groundbreaking PTSD treatment options that are drug-free and trauma-free, offering hope for recovery through advanced medical devices.
City of Hope Opens Trial to Test Bone Medication for Early Type 1 Diabetes Treatment
“This is an exciting new application of a known medication that, in addition to potentially protecting and/or expanding the beta cells that remain in early type 1 diabetes patients, might also be able to help other patients with diabetes to increase beta cell number and/or function,” said Fouad R. Kandeel, M.D., Ph.D., the Arthur D. Riggs Distinguished Chair in Diabetes & Metabolism Research at City of Hope and the trial’s co-principal investigator. “We are actively working to enroll qualified patients and look forward to seeing where this trial leads us.”
CRDMO Market Outlook & Forecasts 2024-2029: Increase in Transaction to Build CRDMOs, Demand for Outsourcing, Integration of Advanced Technologies – ResearchAndMarkets.com
The CRDMO Market was valued at USD 196.14 billion in 2023, and is projected to reach USD 328.90 billion by 2029, rising at a CAGR of 9.00%.
Ivy Fertility Physicians & Experts Launch Podcasts
These podcasts offer valuable insights into the fertility journey, empowering patients with knowledge and support from some of the industry’s most trusted voices.
MedCognition Announces Extended Reality (XR) Medical Simulation Training Technology Receives Broad Method Patent from USPTO
Integrated within the company’s PerSim® medical education and training platform, the patented XR-based technology increases training efficacy by providing a safe and controlled environment that closely resembles authentic patient encounters, allowing students to refine their clinical skills and improve preparedness through real-world scenario simulations.
REGENXBIO Reports Positive Biomarker Data from the AFFINITY DUCHENNE ®Trial of RGX-202 Gene Therapy
“RGX-202 is the only next generation gene therapy for Duchenne in a pivotal phase trial. The new data from the age 1-3 cohort builds on the favorable safety and efficacy profile seen in ages 4 and older and reinforces the potential of RGX-202 to serve a wide age range of patients,” said Steve Pakola, M.D., Chief Medical Officer of REGENXBIO.
Science behind “Polly Want a Cracker” Could Guide Future Treatment Design for Speech Disorders
Published online March 19 in the journal Nature, the study mapped the activity of a group of nerve cells in the bird’s brain called the central nucleus of the anterior arcopallium (AAC), which is known to strongly influence the muscles in its vocal organ. Different groups of AAC cells were found to produce sounds akin to consonants and vowels.
Myant Launches Care360: AI-Powered Precision Cardiac Assessments Delivered Directly to Patients and Physicians
“There has been far too little effort to raise awareness about atrial fibrillation—the most common arrhythmia and a leading driver of stroke, heart failure, and mortality,” said Dr. Yaariv Khaykin, Chief Medical Officer of Myant. “Atrial Fibrillation leads to impaired quality of life and affects productivity, yet many patients don’t even realize they have it. Some experience palpitations, others just feel fatigued and attribute it to aging. Many physicians remain unaware of innovations in Atrial Fibrillation management that could transform care. Myant Care360, with direct Atrial Fibrillation assessment referrals, provides unprecedented access to specialized care and early intervention—strategies that have been shown in randomized studies to slow or even reverse the progression of Atrial Fibrillation.”
CharmHealth Elevates Patient Care With Charm AI Scribe
Charm AI Scribe captures the natural dialogue between the patient and provider during a visit and transcribing it in real time.